Researchers are launching the PrevenTRON study to test the experimental drug trontinemab in healthy individuals aged 55 to 80, aiming to determine if it can delay or prevent the o…
Recent research is reshaping our understanding of Alzheimer's disease, traditionally linked to toxic protein buildup. New findings suggest that issues within the cerebral vascular…
A recent study from Duke Health examined the safety and treatment persistence of lecanemab, a new FDA-approved therapy for Alzheimer’s disease, finding that it aligns with clinica…